Andrew Galler
Stock Analyst at Morgan Stanley
(2.01)
# 1,549
Out of 4,417 analysts
24
Total ratings
40%
Success rate
-3.63%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $10.40 | +44.23% | 5 | Nov 9, 2023 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $60.23 | +31.16% | 10 | Aug 1, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $21.99 | -18.14% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $24.44 | +51.39% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $41.97 | +33.43% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $10.39 | +73.24% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $33.01 | +63.59% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $39.91 | +25.28% | 1 | Sep 9, 2022 |
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $10.40
Upside: +44.23%
Immunocore Holdings
Aug 1, 2023
Reiterates: Overweight
Price Target: $79
Current: $60.23
Upside: +31.16%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $21.99
Upside: -18.14%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $24.44
Upside: +51.39%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $41.97
Upside: +33.43%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $10.39
Upside: +73.24%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $33.01
Upside: +63.59%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $39.91
Upside: +25.28%